Penicillin: Classification, Mechanism, Uses, Adverse Effects, Dosage, Contraindications & Drug Interactions

Penicillin: Classification, Mechanism, Uses, Adverse Effects, Dosage, Contraindications & Drug Interactions

Classification of Penicillin

1. Natural Penicillin

2. Semisynthetic Penicillin

3. β-lactamase inhibitors (used in combination)

Mechanism of Action

  • Inhibit bacterial cell wall synthesis
    • Bind to Penicillin-Binding Proteins (PBPs)
    • Inhibit transpeptidase enzyme → prevent cross-linking of peptidoglycan strands
    • Leads to weak cell wall → osmotic lysis
  • Bactericidal (only in actively growing bacteria)
  • Time-dependent killing

Natural Penicillin: Benzyl Penicillin (Penicillin G)

Spectrum: Gram-positive cocci, Gram-negative cocci, some spirochetes (e.g., Treponema pallidum)
Uses:

  • Streptococcal infections, meningococcal meningitis
  • Syphilis
  • Gas gangrene (Clostridium perfringens)
  • Diphtheria (adjunct)

Semisynthetic Penicillin

Penicillin V

  • Acid-stable, oral use, mainly mild streptococcal infections

Cloxacillin

Ampicillin / Amoxicillin

  • Extended spectrum → Gram-negative bacilli (e.g., H. influenzae, E. coli, Salmonella)
  • Amoxicillin: better oral absorption, used in URTI, otitis media, dental infections

Piperacillin

  • Antipseudomonal, used in serious Pseudomonas aeruginosa infections (often with tazobactam)

β-lactamase Inhibitors

Clavulanic acid, Sulbactam, Tazobactam

  • No significant antibacterial action alone
  • Irreversibly bind bacterial β-lactamase → protect penicillin from degradation
  • Examples of combinations:
    • Amoxicillin + clavulanic acid (Augmentin)
    • Piperacillin + tazobactam
    • Ampicillin + sulbactam

Therapeutic Uses (Summary Table)

Drug

Main Uses

Benzyl penicillin

 Syphilis, streptococcal infections, meningitis

Penicillin V

 Mild strep throat, dental infections

Cloxacillin

 MSSA skin & soft tissue infections

Ampicillin

 Meningitis (with gentamicin), enterococcal infections

Amoxicillin

 URTI, otitis media, prophylaxis in rheumatic fever

Piperacillin

 Pseudomonas infections (hospital-acquired)

Adverse Effects

Dosage (General Ranges)

  • Benzyl penicillin: 1–4 million units IV every 4–6 hrs
  • Penicillin V: 250–500 mg orally every 6–8 hrs
  • Cloxacillin: 250–500 mg orally every 6 hrs
  • Ampicillin: 250–500 mg orally every 6 hrs / 1–2 g IV every 4–6 hrs
  • Amoxicillin: 250–500 mg orally every 8 hrs
  • Piperacillin/tazobactam: 3.375–4.5 g IV every 6–8 hrs

Contraindications

  • History of severe hypersensitivity to β-lactams
  • Caution in:
    • Renal impairment
    • Seizure disorders
    • Infectious mononucleosis (↑ rash with ampicillin/amoxicillin)

Drug Interactions

  • Probenecid: ↑ penicillin levels (↓ renal excretion)
  • Methotrexate: ↓ clearance → toxicity risk
  • Aminoglycosides: Synergistic effect (but physically incompatible in same IV line)
  • Tetracyclines: May antagonize penicillin bactericidal effect
  • Oral contraceptives: Possible ↓ efficacy (controversial)
  • Warfarin: Some penicillins alter gut flora → ↑ INR

Memory Tips

  • “Pen G → Give in G(ross) infections” (serious infections)
  • “V → Very acid-stable” (oral)
  • “Cloxa → Clocks staph” (β-lactamase resistant)
  • “Amo & Amp → Ample spectrum” (broad Gram coverage)
  • “Piper → Pseudomonas Piper”
  • Clav/Sulb/Tazo → “Clubs the β-lactamase”

                                                                  END OF THE DOCUMENT

You may like to read more:

1. Antimicrobials Made Simple: Mechanism, Resistance, and Smart Usage

2. Classification of Sulfonamides, Mechanism of Action, Dosage, Adverse Effects, Contraindications, Drug Interactions

3. Classification of Cephalosporins, Monobactams, and Carbapenems

SHARE

Owner

Hi. I’m Writer of Researchsop.com. ’ ’ Please share these SOPs to all concern pharma people for their development. I like to fullfill the need of curious people. These things inspire me to make things looks better.

  • Image
  • Image
  • Image
  • Image
  • Image
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment